Search

everythinglearnresearchcommunity

for

Search:↓

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

FOXN1 gene variants cause low T cells and immune issues from birth.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

The skin and thymus develop similarly to protect and support immunity.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

A specific DNA region is crucial for Foxn1 gene expression in thymus cells but not in hair follicles.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.